EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Identification of Tissue miRNA Signatures for Pancreatic Ductal Adenocarcinoma

Carlo Caputo iD, Michela Falco iD, Anna Grimaldi iD, Angela Lombardi, Chiara Carmen Miceli, Mariateresa Cocule, Marco Montella iD, Luca Pompella iD, Giuseppe Tirino iD, Severo Campione, Chiara Tammaro, Antonio Cossu iD und 12 weitere

Cancers · 18.02.2024 · 16 (4) · 824

DOI: 10.3390/cancers16040824 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancers, online erschienen am 18.02.2024. Verfasst von Carlo Caputo und 23 weiteren Autor:innen. Beteiligte Einrichtung: Department of Precision Medicine, University of Campania "Luigi Vanvitelli", Via L. De Crecchio 7, 80138 Naples, Italy. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Campania L. Vanvitelli through the grant VALERE, Ministero Italiano per lo Sviluppo Economico (MISE).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pancreatic ductal adenocarcinoma (PDAC), a neoplasm of the gastrointestinal tract, is the most common pancreatic malignancy (90%) and the fourth highest cause of cancer mortality worldwide. Surgery intervention is currently the only strategy able to offer an advantage in terms of overall survival, but prognosis remains poor even for operated patients. Therefore, the development of robust biomarkers for early diagnosis and prognostic stratification in clinical practice is urgently needed. In this work, we investigated deregulated microRNAs (miRNAs) in tissues from PDAC patients with high (G3) or low (G2) histological grade and with (N+) or without (N−) lymph node metastases. miRNA expression profiling was performed by a comprehensive PCR array and subsequent validation by RT-qPCR. The results showed a significant increase in miR-1-3p, miR-31-5p, and miR-205-5p expression in G3 compared to G2 patients (** p < 0.01; *** p < 0.001; *** p < 0.001). miR-518d-3p upregulation and miR-215-5p downregulation were observed in N+ compared to N− patients. A statistical analysis performed using OncomiR program showed the significant involvement (p < 0.05) of two miRNAs (miR-31 and miR-205) in the histological grade of PDAC patients. Also, an expression analysis in PDAC patients showed that miR-31 and miR-205 had the highest expression at grade 3 compared with normal and other tumor grades. Overall, survival plots confirmed that the overexpression of miR-31 and miR-205 was significantly correlated with decreased survival in TCGA PDAC clinical samples. A KEGG pathway analysis showed that all three miRNAs are involved in the regulation of multiple pathways, including the Hippo signaling, adherens junction and microRNAs in cancer, along with several target genes. Based on in silico analysis and experimental validation, our study suggests the potential role of miR-1-3p, miR-31-5p, and miR-205-5p as useful clinical biomarkers and putative therapeutic targets in PDAC, which should be further investigated to determine the specific molecular processes affected by their aberrant expression.

Schlagwörter

Stichwörter der Autor:innen

biomarkersdiagnosismicroRNAspancreatic ductal adenocarcinomaprognosis

Autor:innen und Institutionen

  • Department of Precision Medicine, University of Campania "Luigi Vanvitelli", Via L. De Crecchio 7, 80138 Naples, Italy.
  • Laboratory of Precision and Molecular Oncology, Institute of Genetic Research, Biogem Scarl, Contrada Camporeale, 83031 Ariano Irpino, Italy.
  • U.P. Cytometric and Mutational Diagnostics, AOU Policlinico, University of Campania "Luigi Vanvitelli", Via Luciano Armanni 5, 83031 Naples, Italy.
  • Department of Precision Medicine, Division of Medical Oncology, University of Campania "Luigi Vanvitelli", Via L. De Crecchio 7, 80138 Naples, Italy.
  • Department of Mental and Physical Health and Preventive Medicine, UOC Pathological Anatomy, University of Campania "Luigi Vanvitelli", Via Luciano Armanni 5, 83031 Naples, Italy.
  • Division of Anatomic Pathology, A.O.R.N. Antonio Cardarelli, 80131 Naples, Italy.

ORCID-Profile: Carlo Caputo, Michela Falco, Anna Grimaldi, Marco Montella, Luca Pompella, Giuseppe Tirino, Antonio Cossu, Margherita Maioli, Donatella Coradduzza, Alessandro Ottaiano, Michele Caraglia, Gabriella Misso

Förderung

  • University of Campania L. Vanvitelli through the grant VALERE
  • Ministero Italiano per lo Sviluppo Economico (MISE)

Zitieren

APA

Caputo, C., Falco, M., Grimaldi, A., Lombardi, A., Miceli, C. C., Cocule, M., Montella, M., Pompella, L., Tirino, G., Campione, S., Tammaro, C., Cossu, A., Fenu Pintori, G., Maioli, M., Coradduzza, D., Savarese, G., Fico, A., Ottaiano, A., Conzo, G., …, & Misso, G. (2024). Identification of Tissue miRNA Signatures for Pancreatic Ductal Adenocarcinoma. Cancers, 16(4), 824. https://doi.org/10.3390/cancers16040824

Vancouver

Caputo C, Falco M, Grimaldi A, Lombardi A, Miceli CC, Cocule M, et al. Identification of Tissue miRNA Signatures for Pancreatic Ductal Adenocarcinoma. Cancers. 2024;16(4):824. doi:10.3390/cancers16040824

BibTeX
@article{Caputo2024,
  author = {Caputo, Carlo and Falco, Michela and Grimaldi, Anna and Lombardi, Angela and Miceli, Chiara Carmen and Cocule, Mariateresa and Montella, Marco and Pompella, Luca and Tirino, Giuseppe and Campione, Severo and Tammaro, Chiara and Cossu, Antonio and Fenu Pintori, Grazia and Maioli, Margherita and Coradduzza, Donatella and Savarese, Giovanni and Fico, Antonio and Ottaiano, Alessandro and Conzo, Giovanni and Tathode, Madhura S and Ciardiello, Fortunato and Caraglia, Michele and De Vita, Ferdinando and Misso, Gabriella},
  title = {Identification of Tissue miRNA Signatures for Pancreatic Ductal Adenocarcinoma},
  journal = {Cancers},
  year = {2024},
  volume = {16},
  number = {4},
  pages = {824},
  doi = {10.3390/cancers16040824}
}
Kostenlos starten →